EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms
- Conditions
- Duodenal ObstructionGastric Outlet Obstruction
- Interventions
- Device: EVOLUTION® Duodenal Stent
- Registration Number
- NCT00991614
- Lead Sponsor
- Cook Group Incorporated
- Brief Summary
The objective of this investigation is to compile clinical experience on the use of the Evolution® Duodenal Stent (Cook Ireland), a CE marked device intended for the palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. It is not the goal to change the usual treatment practice of the investigator or the center, nor to collect information on uses outside the product's indications. Patients will be treated as per usual medical practices.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
- Patients for whom this device would be chosen in standard practice
- Patients for whom this device would not normally be chosen in standard practice
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description EVOLUTION® Duodenal Stent EVOLUTION® Duodenal Stent -
- Primary Outcome Measures
Name Time Method Patency of the stent 14 days
- Secondary Outcome Measures
Name Time Method Procedural success, implant duration, symptom resolution up to 6 months
Trial Locations
- Locations (6)
IRCCS Instituto Clinico Humanitas
🇮🇹Milan, Italy
Westmead Hospital
🇦🇺Sydney, Australia
Hopital Saint-Luc / CHUM
🇨🇦Montreal, Quebec, Canada
U.O. Endoscopia Digestiva Chirurgica
🇮🇹Rome, Italy
Institution for Clinical and Experimental Medicine
🇨🇿Praha, Czech Republic
Erasmus MC University Medical Center
🇳🇱Rotterdam, Netherlands